Victory Capital Management Inc. Sells 88,534 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

Victory Capital Management Inc. cut its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 6.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,241,865 shares of the company's stock after selling 88,534 shares during the quarter. Victory Capital Management Inc. owned 0.98% of Surgery Partners worth $26,290,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the stock. KBC Group NV grew its holdings in Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company's stock worth $77,000 after acquiring an additional 576 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. grew its position in shares of Surgery Partners by 747.6% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company's stock worth $124,000 after buying an additional 3,379 shares during the last quarter. Versor Investments LP purchased a new position in shares of Surgery Partners during the third quarter valued at approximately $271,000. MeadowBrook Investment Advisors LLC raised its holdings in shares of Surgery Partners by 16.6% during the fourth quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock valued at $218,000 after acquiring an additional 1,460 shares in the last quarter. Finally, Empowered Funds LLC purchased a new stake in Surgery Partners in the fourth quarter worth $245,000.

Surgery Partners Stock Performance

NASDAQ SGRY traded down $0.01 during trading hours on Friday, hitting $23.60. The company's stock had a trading volume of 849,170 shares, compared to its average volume of 1,067,567. The company's 50 day simple moving average is $23.53 and its two-hundred day simple moving average is $26.14. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The company has a market cap of $3.01 billion, a P/E ratio of -49.17, a price-to-earnings-growth ratio of 19.21 and a beta of 2.73. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $33.97.

Remove Ads

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings data on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating analysts' consensus estimates of $0.38 by $0.01. The company had revenue of $864.40 million during the quarter, compared to analysts' expectations of $828.09 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. As a group, sell-side analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Insider Transactions at Surgery Partners

In other Surgery Partners news, insider Marissa Brittenham sold 3,156 shares of the stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the completion of the sale, the insider now owns 63,408 shares in the company, valued at approximately $1,527,498.72. This represents a 4.74 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Jason Eric Evans sold 26,520 shares of the business's stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.65, for a total value of $680,238.00. Following the completion of the transaction, the chief executive officer now owns 560,698 shares in the company, valued at $14,381,903.70. The trade was a 4.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 106,622 shares of company stock worth $2,717,860 in the last quarter. Company insiders own 2.30% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the stock. Royal Bank of Canada cut their target price on shares of Surgery Partners from $49.00 to $35.00 and set an "outperform" rating on the stock in a research note on Wednesday, November 20th. JPMorgan Chase & Co. cut their price objective on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a research report on Tuesday, December 3rd. Bank of America started coverage on Surgery Partners in a research report on Monday, December 16th. They issued a "buy" rating and a $30.00 target price for the company. Finally, Macquarie dropped their price target on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research report on Tuesday. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, Surgery Partners has a consensus rating of "Moderate Buy" and an average target price of $36.63.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.